Scientific Opinion on the substantiation of health claims related to taurine and “immune system protection” (ID 611), “metabolism processes” (ID 613), contribution to normal cognitive function (ID 1659), maintenance of normal cardiac function (ID 1661), maintenance of normal muscle function (ID 1949) and delay in the onset of physical fatigue during exercise (ID 1958) pursuant to Article 13(1) of Regulation (EC) No 1924/2006

Samankaltaisia teoksia

• Scientific Opinion on the substantiation of health claims related to taurine and “immune system protection” (ID 611), “metabolism processes” (ID 613), contribution to normal cognitive function (ID 1659), maintenance of normal cardiac function (ID 1661), maintenance of normal muscle function (ID 1949) and delay in the onset of physical fatigue during exercise (ID 1958) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
  Tekijä: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Julkaistu: (2011-04-01)
• Scientific Opinion on the substantiation of health claims related to copper and reduction of tiredness and fatigue (ID 272), maintenance of the normal function of the nervous system (ID 1723), maintenance of the normal function of the immune system (ID 1725) and contribution to normal energy‐yielding metabolism (ID 1729) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
  Tekijä: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Julkaistu: (2011-04-01)
• Scientific Opinion on the substantiation of health claims related to L‐tryptophan and maintenance of normal sleep (ID 596, 1671), enhancement of mood (ID 596), contribution to normal cognitive function (ID 596), and contribution to the maintenance or achievement of a normal body weight (ID 604) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
  Tekijä: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Julkaistu: (2011-04-01)
• Scientific Opinion on the substantiation of health claims related to L arginine and “immune system functions” (ID 455, 1713), growth or maintenance of muscle mass (ID 456, 1712, 4681), normal red blood cell formation (ID 456, 664, 1443, 1712), maintenance of normal blood pressure (ID 664, 1443), improvement of endothelium‐dependent vasodilation (ID 664, 1443, 4680), “physical performance and condition” (ID 1820), “système nerveux” (ID 608), maintenance of normal erectile function (ID 649, 4682), contribution to normal spermatogenesis (ID 650, 4682), “function of the intestinal tract” (ID 740), and maintenance of normal ammonia clearance (ID 4683) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
  Tekijä: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Julkaistu: (2011-04-01)
• Scientific Opinion on the substantiation of health claims related to gamma linolenic acid (GLA) and maintenance of normal blood LDL cholesterol concentrations (ID 2661, 4452, 4453), maintenance of normal blood pressure (ID 2662), reduction of menstrual discomfort (ID 495, 640, 1773, 1775), contribution to normal cognitive function (ID 1770), maintenance of the barrier function of the skin (ID 499, 591, 639, 676, 1554, 2003, 2065), “function of the cell membrane” (ID 1769), maintenance of normal structure, elasticity and appearance of the skin (ID 2660, 4296), and “anti‐inflammatory properties” (ID 4454) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
  Tekijä: EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
  Julkaistu: (2011-04-01)